Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh

Environmental Microbiology

Volumn 19, Issue 1, 2017, Pages 237-250

  Sarker, Shafiqul Alam ^a   Berger, Bernard ^b   Deng, Ying ^b   Kieser, Silas ^b   Foata, Francis ^b   Moine, Deborah ^b   Descombes, Patrick ^b   Sultana, Shamima ^a   Huq, Sayeeda ^a   Bardhan, Pradip Kumar ^a   Vuillet, Valérie ^b   Praplan, Fabienne ^b   Brüssow, Harald ^b  

^a ICDDRB Clinical Sciences Division   (Bangladesh)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADVERSE EFFECTS; BACTERIOPHAGE; BANGLADESH; BIOLOGICAL THERAPY; CHILD; CONTROLLED STUDY; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMAN; MALE; MICROBIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

BACTERIOPHAGES; BANGLADESH; BIOLOGICAL THERAPY; CHILD; CHILD, PRESCHOOL; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; MALE; RNA, RIBOSOMAL, 16S;

EID: 85006377680     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/1462-2920.13574     Document Type: Article

References (32)

1. Barletta, F., Ochoa, T.J., Mercado, E., Ruiz, J., Ecker, L., Lopez, G., et al. (2011) Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin Infect Dis 53: 1223–1229.
2. Bourdin, G., Schmitt, B., Marvin Guy, L., Germond, J.E., Zuber, S., Michot, L., et al. (2014a) Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale. Appl Environ Microbiol 80: 1469–1476.
3. Bourdin, G., Navarro, A., Sarker, S.A., Pittet, A.C., Qadri, F., Sultana, S., et al. (2014b) Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microb Biotechnol 7: 165–176.
4. Brüssow, H. (2005) Phage therapy: the Escherichia coli experience. Microbiology 151: 2133–2140.
5. Brüssow, H. (2016) How stable is the human gut microbiota? And why this question matters. Environ Microbiol 18: 2779–2783.
6. Brüssow, H., Sidoti, J., Link, H., Hoang, Y.K., Barclay, D., Dirren, H., and Freire, W.B. (1990) Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children. J Infect Dis 162: 974–977.
7. Bruttin, A., and Brüssow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49: 2874–2878.
8. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Dillmann, M.L., Kutter, E., Qadri, F., et al. (2004) Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh. J Bacteriol 186: 8287–8294.
9. David, L.A., Weil, A., Ryan, E.T., Calderwood, S.B., Harris, J.B., Chowdhury, F., et al. (2015) Gut microbial succession follows acute secretory diarrhea in humans. MBio 6: e00381–e00315.
10. Dethlefsen, L., and Relman, D.A. (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108(Suppl.1): 4554–4561.
11. Flores, G.E., Caporaso, J.G., Henley, J.B., Rideout, J.R., Domogala, D., Chase, J., et al. (2014) Temporal variability is a personalized feature of the human microbiome. Genome Biol 15: 531–544.
12. Galtier, M., De Sordi, L., Maura, D., Arachchi, H., Volant, S., Dillies, M.A., and Debarbieux, L. (2016) Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environ Microbiol 18: 2237–2245.
13. Hurley, J.C. (1992) Antibiotic-induced release of endotoxin: A reappraisal. Clin Infect Dis 15: 840–854.
14. Jiang, Z.D., Lowe, B., Verenkar, M.P., Ashley, D., Steffen, R., Tornieporth, N., et al. (2002) Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185: 497–502.
15. Junick, J., and Blaut, M. (2012) Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol 78: 2613–2622.
16. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., et al. (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108(Suppl.1): 4578–4585.
17. Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., Nasrin, D., Farag, T.H., Panchalingam, S., et al. (2013) Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382: 209–222.
18. Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., and Singh, U. (2013) Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One 8: e53838.
19. Liu, J., Kabir, F., Manneh, J., Lertsethtakarn, P., Begum, S., Gratz, J., et al. (2014) Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect Dis 14: 716–724.
20. Martinez, L. (2012) The evolving threat of antimicrobial resistance. Options for Action. Geneva: WHO.
21. McCallin, S., Sarker, S.A., Barretto, C., Sultana, S., Berger, B., Huq, S., et al. (2013) Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. Virology 443: 187–196.
22. Qadri, F., Svennerholm, A.M., Faruque, A.S., and Sack, R.B. (2005) Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 18: 465–483.
23. Sarker, S.A., McCallin, S., Barretto, C., Berger, B., Pittet, A.C., Sultana, S., et al. (2012) Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 434: 222–232.
24. Sarker, S.A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., et al. (2016) Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4: 124–137.
25. Simeoni, U., Berger, B., Junick, J., Blaut, M., Pecquet, S., Rezzonico, E., et al. (2015) Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446. Environ Microbiol 18: 2185–2195.
26. Smith, M.I., Yatsunenko, T., Manary, M.J., Trehan, I., Mkakosya, R., Cheng, J., et al. (2013) Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339: 548–554.
27. Subramanian, S., Huq, S., Yatsunenko, T., Haque, R., Mahfuz, M., Alam, M.A., et al. (2014) Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510: 417–421.
28. Taniuchi, M., Sobuz, S.U., Begum, S., Platts-Mills, J.A., Liu, J., Yang, Z., et al. (2013) Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis 208: 1794–1802.
29. Thaiss, C.A., Zeevi, D., Levy, M., Zilberman-Schapira, G., Suez, J., Tengeler, A.C., et al. (2014) Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 159: 514–529.
30. Vandenheuvel, D., Lavigne, R., and Brüssow, H. (2015) Bacteriophage therapy: Advances in formulation strategies and human clinical trials. Annu Rev Virol 2: 599–618.
31. Weiss, M., Denou, E., Bruttin, A., Serra-Moreno, R., Dillmann, M.L., and Brüssow, H. (2009) In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393: 16–23.
32. Yang, C.J., Lee, N.Y., Lin, Y.H., Lee, H.C., Ko, W.C., Liao, C.H., et al. (2010) Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: incidence and risk factors. Clin Infect Dis 51: 976–979.